Benova D
Int J Radiat Oncol Biol Phys. 1987 Jan;13(1):117-9. doi: 10.1016/0360-3016(87)90268-9.
Pretreatment by intraperitoneal administration of WR 2721 at 400 mg/kg body weight in mice receiving 4.0 Gy X rays was found to have an appreciable antimutagenic effect with regard to reciprocal translocation induction in spermatogonia. The effectiveness of the product tested proved superior to that of a radioprotective mixture of ATP-AET-serotonin given at optimal dose ratio--360, 24, and 8 mg/kg body weight, respectively. The RF (Reduction Factor) was 2.4 for WR 2721 and 1.8 for the mixture. The effect observed indicated WR 2721 to have potential capabilities for reducing the genetic risk of radiation in male individuals.
在接受4.0 Gy X射线照射的小鼠中,以400 mg/kg体重腹腔注射WR 2721进行预处理,结果发现其对精原细胞中相互易位的诱导具有明显的抗诱变作用。所测试产品的有效性被证明优于以最佳剂量比例(分别为360、24和8 mg/kg体重)给予的ATP-AET-血清素辐射防护混合物。WR 2721的RF(降低因子)为2.4,混合物的RF为1.8。观察到的效果表明WR 2721具有降低男性个体辐射遗传风险的潜在能力。